William Blair & Company’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $79.9K | Hold |
37,884
| – | – | ﹤0.01% | 1551 |
|
|
2025
Q1 | $46.2K | Hold |
37,884
| – | – | ﹤0.01% | 1600 |
|
|
2024
Q4 | $48.9K | Hold |
37,884
| – | – | ﹤0.01% | 1611 |
|
|
2024
Q3 | $104K | Hold |
37,884
| – | – | ﹤0.01% | 1533 |
|
|
2024
Q2 | $85.6K | Hold |
37,884
| – | – | ﹤0.01% | 1532 |
|
|
2024
Q1 | $90.5K | Hold |
37,884
| – | – | ﹤0.01% | 1521 |
|
|
2023
Q4 | $62.9K | Hold |
37,884
| – | – | ﹤0.01% | 1565 |
|
|
2023
Q3 | $72.7K | Hold |
37,884
| – | – | ﹤0.01% | 1546 |
|
|
2023
Q2 | $54.6K | Hold |
37,884
| – | – | ﹤0.01% | 1588 |
|
|
2023
Q1 | $79.6K | Hold |
37,884
| – | – | ﹤0.01% | 1526 |
|
|
2022
Q4 | $42.8K | Sell |
37,884
-3,000
| -7% | -$3.39K | ﹤0.01% | 1594 |
|
|
2022
Q3 | $67K | Hold |
40,884
| – | – | ﹤0.01% | 1555 |
|
|
2022
Q2 | $54K | Buy |
+40,884
| New | +$54K | ﹤0.01% | 1620 |
|
|
2021
Q4 | – | Sell |
-10,756
| Closed | -$42K | – | 1992 |
|
|
2021
Q3 | $42K | Hold |
10,756
| – | – | ﹤0.01% | 1698 |
|
|
2021
Q2 | $34K | Hold |
10,756
| – | – | ﹤0.01% | 1730 |
|
|
2021
Q1 | $23K | Hold |
10,756
| – | – | ﹤0.01% | 1737 |
|
|
2020
Q4 | $24K | Hold |
10,756
| – | – | ﹤0.01% | 1689 |
|
|
2020
Q3 | $29K | Hold |
10,756
| – | – | ﹤0.01% | 1551 |
|
|
2020
Q2 | $33K | Hold |
10,756
| – | – | ﹤0.01% | 1486 |
|
|
2020
Q1 | $21K | Sell |
10,756
-23,364
| -68% | -$45.6K | ﹤0.01% | 1482 |
|
|
2019
Q4 | $98K | Hold |
34,120
| – | – | ﹤0.01% | 1413 |
|
|
2019
Q3 | $125K | Buy |
34,120
+23,364
| +217% | +$85.6K | ﹤0.01% | 1352 |
|
|
2019
Q2 | $45K | Buy |
+10,756
| New | +$45K | ﹤0.01% | 1509 |
|